| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $267.0M | +3.8% |
| Cost of Revenue | $117.6M | -26.1% |
| R&D Expense | $93.3M | -14.7% |
| SG&A Expense | $167.7M | -12.6% |
| Operating Income | -$111.7M | +45.0% |
| Interest Expense | $27.2M | -33.0% |
| Pre-tax Income | $28.5M | +112.0% |
| Income Tax | -$380K | +0.0% |
| Net Income | $28.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $126.0M | +22.4% |
| Short-term Investments | $14.9M | +0.0% |
| Accounts Receivable | $111.3M | -57.3% |
| Inventory | $70.1M | +12.0% |
| Current Assets | $341.6M | -28.2% |
| Total Assets | $448.5M | -28.8% |
| Current Liabilities | $283.0M | -14.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | +88.3% |
| Investing Cash Flow | $230.3M | +59.2% |
| Financing Cash Flow | -$187.0M | -368.6% |
| +112.0% |
| EPS (Basic) | $0.25 | +109.9% |
| EPS (Diluted) | $0.25 | +109.9% |
| Total Liabilities |
| $580.5M |
| -29.5% |
| Stockholders' Equity | -$132.0M | +31.8% |